Literature DB >> 12794412

Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.

Bernd G Stegmayr1, Ravjet Banga, Lars Berggren, Rut Norda, Anders Rydvall, Tomas Vikerfors.   

Abstract

OBJECTIVE: To describe the outcome of using a rescue therapy including plasma exchange given to patients with a progressive acute disseminated intravascular coagulation and multiple organ dysfunction syndrome. STUDY
DESIGN: Retrospective study.
SETTING: University and county hospital. PATIENTS: Included were 76 consecutive patients (41 men and 35 women) treated with plasma exchange as rescue therapy besides optimal conventional therapy during a progressive course of disseminated intravascular coagulation and multiple organ dysfunction syndrome, including acute renal failure. Of the 76 patients, 66% needed dialysis. The distribution was hemodialysis in 76%, continuous arteriovenous hemofiltration in 36%, continuous venovenous hemodialysis in 12%, and peritoneal dialysis in 24%. The median organ-failure score was 5 (range, 1-6). Seventy-two percent required mechanical ventilation; septic shock was present in 88%. The median septic shock score was 4 (range, 2-4). Nine patients had another reason than sepsis for the multiple organ dysfunction syndrome. INTERVENTION: Plasma exchange (centrifugation technique) was performed until disseminated intravascular coagulation was reversed (median, two times; range, 1-14). Besides antibiotics and fluid administration, most patients received heparin or low molecular weight heparin (77%), steroids (87%), and inotropes (88%). More than one vasoactive drug was used in 57% of the patients.
MEASUREMENTS AND MAIN RESULTS: Eighty-two percent of the patients survived and could leave the hospital. The previously observed survival rates by others for this category of patients would be <20%, and thus, the outcome in this study is significantly better.
CONCLUSION: Plasma exchange using plasma as replacement may, in addition to conventional intensive care, help to reverse severe progressive disseminated intravascular coagulation and multiple organ dysfunction syndrome and improve survival.

Entities:  

Mesh:

Year:  2003        PMID: 12794412     DOI: 10.1097/01.CCM.0000064742.00981.14

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

1.  Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.

Authors:  Pritesh Patel; Veena Nandwani; John Vanchiere; Steven A Conrad; L Keith Scott
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

Review 2.  [Progress in therapy of infection].

Authors:  U Müller-Werdan; M Buerke; K Werdan
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

3.  Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network.

Authors:  Esra Sevketoglu; Dincer Yildizdas; Ozden Ozgur Horoz; Hasan Serdar Kihtir; Tanil Kendirli; Suleyman Bayraktar; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2014-10       Impact factor: 3.624

Review 4.  The role of plasmapheresis in critical illness.

Authors:  Trung C Nguyen; Joseph E Kiss; Jordana R Goldman; Joseph A Carcillo
Journal:  Crit Care Clin       Date:  2012-07       Impact factor: 3.598

Review 5.  Plasma exchange therapy for thrombotic microangiopathies.

Authors:  Trung C Nguyen; Yong Y Han
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

6.  Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support.

Authors:  Yu Kawai; Timothy T Cornell; Elaine G Cooley; Craig N Beckman; Paula K Baldridge; Theresa A Mottes; Kera E Luckritz; Kathryn S Plomaritas; J Michael Meade; Folafoluwa O Odetola; Yong Y Han; Neal B Blatt; Gail M Annich
Journal:  Pediatr Crit Care Med       Date:  2015-05       Impact factor: 3.624

Review 7.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

8.  Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.

Authors:  Trung C Nguyen; Yong Y Han; Joseph E Kiss; Mark W Hall; Andrea Cortese Hassett; Ron Jaffe; Richard A Orr; Janine Janosky; Joseph A Carcillo
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Therapeutic Plasma Exchange in Children With Thrombocytopenia-Associated Multiple Organ Failure: The Thrombocytopenia-Associated Multiple Organ Failure Network Prospective Experience.

Authors:  James D Fortenberry; Trung Nguyen; Jocelyn R Grunwell; Rajesh K Aneja; Derek Wheeler; Mark Hall; Geoffrey Fleming; Rod Tarrago; Sandra Buttram; Heidi Dalton; Yong Han; Kirk A Easley; Andrea Knezevic; Tian Dai; Matthew Paden; Joseph A Carcillo
Journal:  Crit Care Med       Date:  2019-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.